Immunopathology, Vaccine Development and Treatment of Viruses
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Immunology".
Deadline for manuscript submissions: 30 April 2024 | Viewed by 173
Special Issue Editor
Interests: ebolaviruses; Marburg virus; Nipah virus; Hendra virus; Lassa virus; BSL-4 pathogens; emerging viruses; nonhuman primate models; development of vaccines and therapeutics; spatial biology
Special Issue Information
Dear Colleagues,
Viral infections continue to pose significant health and social challenges globally. Diseases caused by viruses can range from mild to severe, affecting millions of people each year and causing substantial morbidity and mortality. The continued emergence and re-emergence of viruses highlight a critical need for comprehensive research in understanding immunopathological mechanisms, developing effective vaccines and advancing treatment strategies. Addressing these issues is crucial for improving public health and enhancing our preparedness for future viral outbreaks.
This Special Issue aims to collect recent molecular and preclinical research findings on a wide range of topics related to immunopathology, vaccine development and the treatment of viruses, including, but not limited, to:
- Immunological responses to viral infections: mechanisms of immune responses against viral pathogens, including the role of innate and adaptive immunity;
- Vaccine development and design: novel approaches and strategies for the development of vaccines against various viruses;
- Antiviral therapeutics: discovery and development of antiviral drugs, including small molecules, biologics, monoclonal antibodies and other therapeutic interventions;
- Immunopathological studies: immunopathological aspects of viral infections, focusing on host–virus interactions, immune evasion strategies employed by viruses and virus-associated tissue damage;
- Emerging viral diseases: addressing challenges posed by emerging and re-emerging viruses, highlighting innovative approaches to understand, prevent and treat these infections.
Given your valuable contributions to this research field, we warmly welcome original research papers and reviews on these broad and relevant topics.
Best regards,
Dr. Courtney B. Woolsey
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- virus
- immunopathology
- vaccines
- treatments
- therapeutics
- pathogenesis
- molecular virology
- emerging viruses
